Secretion and degradation of mutant leucine-specific binding protein molecules containing C-terminal deletions by Landick, Robert C. et al.
Journal of Cellular Biochemistry 24331-344 (1984) 
Protein Transport and Secretion 265-278 
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The leucine-specific binding protein (LS-BP), a periplasmic component of the 
Escherichia coli high-affinity leucine transport system, is initially synthesized in a 
precursor form with a 23 amino acid N-terminal leader sequence that is removed 
during secretion of the protein into the periplasm. Using in vitro mutagenesis, 
deletion mutants of the LS-BP gene have been constructed with altered or missing 
amino acid sequences in the C-terminal portion of the protein. These altered 
binding proteins exhibited normal processing and secretion but were rapidly 
degraded in the periplasmic space. In the presence of an uncoupler of the trans- 
membrane potential (CCCP) the precursor forms accumulated in the membrane 
and were protected from degradation. The altered binding proteins also were 
secreted by spheroplasts of E coli, after which they were easily detected. 
Key words: leucine .binding protein, protein secretion, proteolysis, degradation, site-directed 
mutagenesis, membrane potential, processing, periplasmic proteins 
Escherichia coli, like other gram-negative bacteria, contains a periplasmic space 
between its inner and outer membranes. This periplasmic space contains several types 
of proteins, such as nutrient-binding proteins [ 1-41 and hydrolytic enzymes [5,6], that 
must be translocated across the inner membrane. Periplasmic proteins are synthesized 
as precursors with 20-25 amino acid N-terminal extensions [2,7]. This signal se- 
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quence is removed by proteolytic processing by a leader peptidase [8,9] during the 
secretory process. The processing step can be blocked by treating cells with iono- 
phores such as carbonylcyanide-m-chlorophenylhydrazone (CCCP) or valinomycin 
[ 10-131. Inhibition of processing prevents release of the unprocessed proteins into the 
periplasm [ 101. 
We have studied the leucine-specific binding protein (LS-BP), a periplasmic 
component of the high-affinity leucine transport system [14-161, as a model for 
periplasmic protein secretion. For these studies we have constructed mutant LS-BP 
genes that contain deletions near the 3' end of the gene and therefore code for LS-BP 
molecules with altered or missing amino acid sequences near their C-termini. To 
construct these deletions we cleaved plasmid p o x 7  [16] at a unique Bam HI site 
equivalent to amino acid 254 of the mature LS-BP and removed varying amounts of 
the gene with the double-stranded exonuclease BAL-31 [ 171. After transforming the E 
coli recA strain AM04 with the religated plasmid we analyzed the structure of many 
clones and chose three for further experimentation. One plasmid, pOX7AB14, coded 
for a LS-BP molecule (LS-BPAB14) that was missing 234 nucleotides around the 
Bam HI site (78 amino acids) and was fused so that the remaining portion of LS- 
BPAB14 was translated in the correct reading frame. The other two plasmids, 
pOX7AC 16 and pOX7AG 13, had smaller deletions around the Bam HI site, but coded 
for truncated proteins due to fusion out of frame. 
In this report we (1) describe the structural analysis of LS-BPAB14, LS- 
BPAC16, and LS-BPAG13, (2) demonstrate that all three altered proteins are secreted 
in spheroplasts of E coli, and (3) show that these altered LS-BP molecules are 
degraded by periplasmic proteases so that secreted forms are not stable in the 
periplasm. Finally, we discuss the implications of these results for experimental 
strategies designed to secrete ordinarily nonsecretory proteins. 
EXPERIMENTAL PROCEDURES 
Materials 
CCCP was purchased from Sigma Chemical Company; [35S]methionine (> 800 
Ci/mmole), from New England Nuclear; T4 DNA ligase, from New England Biolabs; 
restriction enzymes and BAL-31 nuclease, from Bethesda Research Labs, Inc; and 
goat antirabbit IgG antisera, from Miles. Rabbit antisera against the LIV-BP was 
prepared by conventional methods and was previously found to be cross-reactive with 
the LS-BP [18]. E coli strain A D 0 4  (livH, livR, argG6, his-1, trp-31, recA, pdxC, 
mtl-2, xyl-7, malA1, gal-6, lacZ4, str-104, tonA2, tsx-1, supE44) was constructed by 
standard genetic techniques from the E coli Genetic Stock Center (New Haven, CT 
06510) strain CGSC 4273. The construction of plasmid p o x 7  has been described 
DNA Methods 
Plasmid DNA was prepared by the cleared lysate procedure of Clewell and 
Helinski [ 191 and purified by buoyant density centrifugation in ethidium bromide/ 
CsCl gradients. All restriction enzyme digestions were conducted under the conditions 
recommended by the supplier. Transformation of E coli was performed as previously 
described [20]. DNA sequencing was performed as described by Maxam and Gil- 
bert [2 l]. 
[ 161. 
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Assays for Synthesis, Processing, and Secretion of Plasmid-Coded 
Proteins 
Plasmid-bearing cells to be assayed for synthesis and processing of secretory 
proteins were grown in 10 mi of 4-morpholine propanesulfonic acid (MOPS)-rich 
medium [22] without leucine and containing 20 pg/ml ampicillin to an O D m  of 0.8. 
Treatment of cells for the assay of CCCP inhibition of secretory protein processing 
and for the assay of secretory protein secretion of spheroplasts was done as previously 
described [ 10,13,23]. 
Assays for protein synthesis and secretion in spheroplasts were conducted 
essentially as described [lo, 13,231. Briefly, cells containing recombinant plasmids 
were grown in either MOPS-rich medium without leucine or MOPS-minimal medium 
with appropriate supplements and then treated with lysozyme-EDTA in 0.75 M 
sucrose, 10 mM TRIS-HC1, pH 8.0, on ice. After addition of DNase, the spheroplasts 
were pelleted by centrifugation at 10,OOOg for 15 min. The spheroplasts were resus- 
pended in MOPS-rich medium containing 12% sucrose and lacking methionine. The 
spheroplasts were labeled with L-[35S]methionine at 37°C for 20-30 min and then 
centrifuged at 12,OOOg for 10 min to separate the spheroplasts from the labeling 
medium. The fractions were separately immunoprecipitated as previously described 
(131 and analyzed by SDS polyacrylamide gel electrophoresis. 
Protein Electrophoresis 
SDS polyacrylamide gel electrophoresis was conducted as described by Laem- 
mli [24] in 11% acrylamide gels containing 0.4% bisacrylamide. When the brom- 
phenol blue dye marker reached the bottom of the gel, the gel was removed from the 
electrophoresis apparatus, fixed in 30% methanol, 10% acetic acid in water and 
treated with Enhance (New England Nuclear) according to the manufacturer's instruc- 
tions. The gels were dried and placed against Kodak X-Omat AR-5 film at -70°C 
for autoradiography . 
Construction of LS-BP Deletions 
Plasmid p o x 7  (161, which contains a unique Barn HI site at codon 277 of the 
LS-BP gene (codon 254 of the portion of the gene coding for the mature protein), 
was treated with Barn HI and the linear plasmid was purified by electrophoresis 
through 0.8% agarose in 40 mM TRIS acetate, 1 mM EDTA, pH 7.9, and recovered 
by electroelution in dialysis tubing; 2 pg of the purified, Bam HI-cut plasmid was 
treated with 0.5 units/ml of the double-stranded exodeoxyribonuclease BAL-3 1 [ 171 
in 20 pl of 600 mM NaCl, 12 mM MgC12, 12 mM CaC12, 1 mM EDTA, 20 mM 
TRIS HCl, pH 8.1, for 2 min at 37°C. The reaction was stopped by addition of 50 p1 
of phenol and 200 pl of 0.3 M ammonium acetate. The aqueous phase was recovered 
after centrifugation at 4"C, 10,0oOg, for 10 min and extracted twice with diethyl 
ether. After precipitation by addition of 2.5 volumes of ethanol, the DNA pellet was 
washed with 75% ethanol, dried in vacuo, and redissolved in 30 pl of ligase buffer; 
450 units of T4 DNA ligase were added and the mixture was incubated at 16°C for 
16 hr. The reaction mixture was used to transform E coli strain AE 404 to ampicillin 
resistance; 180 resistant colonies were screened for the presence of a plasmid missing 
the Bam HI site. Of ten plasmids that contained small deletions around the Bam HI 
site, three (pOX7AB14, pOX7AC16, and pOX7AG13) were chosen for further 
characterization. 
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RESULTS 
Structural Analysis of the LS-BP Deletions 
Figure 1 shows restriction enzyme mapping data for plasmids pOX7AB14, 
pOX7AC16, pOX7AG13, and pOX7. Based on the Hinf I digestion patterns, the B14 
deletion was approximately 235 base pairs, the G13 deletion was approximately 196 
base pairs, and the C16 deletion was approximately 138 base pairs. Knowledge of the 
exact location of Taq I restriction enzyme recognition sites from the DNA sequence 
of the LS-BP gene [R. Landick and D.L. Oxender, manuscript in preparation], 
allowed us to define the approximate endpoints of the three deletions as shown in 
Figure 2. All three of the deletions remove the first Taq I site upstream from the Bam 
HI site as evidenced by the absence of the 120-base-pair Taq I fragment (see Fig. 1). 
Since the 742 base-pair fragment at the 5' end of the LS-BP gene is undisturbed in all 
three deletions, we concluded that the 5' end of each deletion was in the 66-base-pair 
Taq I fragment. Since the size of each deletion based on the Taq I digestion was larger 
than the size deduced from the Hinf I digestion pattern, we concluded that the 5' end 
of the deletions must be near the 3' end of the 66-base Taq I fragment, so that, in the 
deletions, this fragment was fused to the large Taq I fragment 3' to the Bam HI site. 
Therefore, beginning around amino acid 230 of the mature LS-BP, the B14 deletion 
removed about 75 amino acids; the G13 deletion, about 65 amino acids; and the C16 
deletion, about 46 amino acids. 
Synthesis and Secretion of the LS-BP Deletion Proteins in Spheroplasts 
To confirm that these three plasmids produced a deleted protein and to find out 
if the proper reading frame was conserved, it was necessary to examine the proteins 
synthesized by these plasmids. We tried several techniques, including coupled in vitro 
transcription/translation, whole cell labeling, and spheroplast labeling to detect syn- 
thesis of the LS-BP deletion proteins. Both in vitro transcription/translation and whole 
cell labeling gave nonreproducible synthesis of the deletion proteins; it appeared that 
they were being proteolytically degraded in these experiments (see Fig. 4 and results 
below). As shown in Figure 3A, however, all three deletion proteins were easily 
detected by [35S]methionine labeling of spheroplasts. All three deletion proteins were 
found in the labeling media, indicating that they were secreted through the cyto- 
plasmic membrane. Control experiments (data not shown) verified that only normally 
secreted proteins were found in the labeling medium using this protocol and the bulk 
of the labeled proteins were retained in the spheroplast pellet. Interestingly, it was 
apparent from the sizes of the three deletion proteins based on the MW standards 
(Fig. 3A) that only the LS-BPAB14 was fused in the correct reading frames. Based 
on the DNA mapping data shown in Figures 1 and 2, both the pOX7AC16 and 
pOX7AG13 plasmids contained smaller deletions than the pOX7AB 14 plasmid, yet 
the protein products LS-BPAG13 and LS-BPAC16 were both smaller than LS- 
BPAB14. Therefore, we concluded that both LS-BPA13 and LS-BPAC16 were fused 
out of frame and produced truncated proteins. To verify that the three deletion proteins 
were processed as well as secreted we ran samples of [35S]methionine-labeled, CCCP- 
treated whole cells (lanes c) containing the pOXAB14, pOX7AC16, and pOX7AG13 
plasmids on the gel whose autoradiograph is shown in Figure 3B. These conditions 
produced the precursors of the deleted LS-PBs and it was clear that the proteins 
secreted in spheroplasts (lanes s) were indeed processed. We did observe that the G13 
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Fig. 1. Gel electrophoresis patterns of restriction endonuclease digestions of pOX7, pox7 deletions, 
and pBR322. The stars mark the fragments that are affected by the deletions. The numbers on the left 
and right of the figure refer to the known sizes in base pairs of the corresponding DNA fragments based 
on the DNA sequence of pBR322 [29] and pOX7 [Landick and Oxender, manuscript in preparation]. 
The band labeled 616p results from partial digestion of the Taq I recognition site at position 1126 of 
pBR322 [29] which is partially protected from cleavage by methylation. 
3; BW G13 C16 pOX7 322 M4 G13 C16 pOX7 
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Fig. 3. Synthesis and secretion of LS-BPAB14, LS-BPAC16, and LS-BPAG13 in spheroplasts. a) 
Spheroplasts of strain AE 404 containing plasmids pOX7, pOX7AB14, pOX7AC16, or pOX7AG13 were 
prepared as described in Experimental Procedures. The spheroplasts were suspended in MOPS-rich 
medium without methionine or leucine and labeled by addition of 10 pCi of [35S]methionine and 
incubation at 37°C for 30 min. Spheroplasts were removed by centrifugation at 12,OOOg for 10 min and 
the supernatant fluid [lanes s, (a)] and pellet fractions [lanes p, (a)] were prepared for irnrnunoprecipita- 
270PTS 
Secretion of Mutant Proteins in E coli JCB:337 
and C16 deletion proteins tended to produce more than one band in the spheroplast 
labeling experiment. In each case, the top band was consistent with the removal of 
the 23-amino-acid signal sequence and we attributed the lower bands to partial 
proteolytic degradation of LS-BPAG 13 and LS-BPAC 16. In separate experiments (not 
shown) we observed much more extensive proteolysis of the deletion proteins when 
the spheroplast labeling was terminated by addition of excess unlabeled methionine. 
Presumably, this allowed synthesis and secretion of sufficient periplasmic proteases 
to cause the increased degradation. 
Synthesis and Degradation of LS-BP Deletion Proteins in Whole Cells 
We also examined processing and looked for secretion of the deletion proteins 
in intact cells. We treated AE 404/pOX7, AE 404/pOX7AB14, AE 404/pOX7AC16, 
and AE 404/pOX7AG13 as described in Experimental Procedures to assay for protein 
synthesis and processing. As shown in Figure 4A, we examined synthesis of LS- 
BPAB14 and LS-BP after 0, 10, 32, and 100 p M  CCCP treatment of cells. A band 
corresponding to LS-BPAB 14 was evident in anti-LIV-BP immunoprecipitation of 
Fig. 3 (continued) 
tion and eIectrophoresis as previously described [13]. b) The lanes labeled c refer to samples from 
CCCP-treated whole cells of AE 404 containing pOX7AB14, pOX7AC16, or pOX7AG13 as described 
in the legend to Figure 4. The lanes labeled s correspond to samples of supernatant of spheroplasts from 
the cells indicated. The multiple bands seen in the C16 and GI3 deletions are presumed to arise from 
partial degradation of the deletion proteins (see text). In each case, the uppermost band is the appropriate 
size for the processed form of the deleted proteins. 
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Fig. 4.  Synthesis and processing of LS-BPAB14, LS-BPAC16, and LS-BPAG13 in whole cells. Cells 
of strain AE 404 containing pOX7, pOX7AB14, pOX7AC16, or pOX7AG13 were grown, labeled, and 
immunoprecipitated as described in Experimental Procedures and elsewhere [ 131. a) AE 404/pOX7 and 
AE 404/pOX7AB14 were treated with 0, 10, 32, or 100 pM CCCP during labeling. The precursor and 
mature forms of the LS-BP (pLS-BP and LS-BP) and LS-BPAB14 (pB14 and B14) are marked. p32K 
and 32K mark the positions of precursor and processed forms of a secretory protein thought to be ompA 
protein [ 161 that are insoluble in the 1 % Triton X- 100 solution used for immunoprecipitation. b) Samples 
of AE 404/pOX7, AE 404/pOX7AC16, and pOX7AG13 were grown, labeled, and immunoprecipitated 
as described for a) CCCP was present at either 100 p M  (+, lanes A, C, and E) or absent (- , lanes B, 
D, and F). 
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whole cell proteins radiolabeled with [35S]methionine for 30 min. CCCP treatment 
shifted this band into an apparent precursor form at approximately the same concen- 
trations required to inhibit processing of the pLS-BP. Figure 4B shows results from 
the same protocol applied to the C16 and GI3 deletions. In this case, only 0- and 100- 
p M  CCCP concentrations were used. In Figure 4B, the bands corresponding to pLS- 
BPAC16 and pLS-BPAG13 are readily apparent in the CCCP-treated cells, but the 
bands corresponding to the processed forms of these proteins in the untreated cells 
are almost completely absent (a faint band corresponding to each processed form is 
visible on the original autoradiograph). We interpreted these results as suggesting that 
the processed forms of the deletion proteins were probably released into the periplasm 
where they were rapidly degraded by periplasmic proteases [5]. Closer examination 
of Figure 4A revealed that the processed form of LS-BPAB14 was also present at 
slightly lower levels than its precursor in equal aliquots of cells. The degradation of 
LS-BPAB14 is apparently slower than the degradation of LS-BPAC16 and LS- 
BPAG13, perhaps because it contains more of the correct amino acid sequence at its 
C-terminus. These results demonstrate that processing of all three deleted proteins is 
detectable. 
Fig. 4 (continued) 
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We also tested to see if LS-BPAB14 was present in the periplasm of pOX7AB14- 
transformed AE 404. We isolated the periplasmic contents of this strain after growth 
in MOPS-rich medium without leucine by osmotic shock treatment [25] and subjected 
them to SDS polyacrylamide gel electrophoresis. While AE 404/pOX7 gave a very 
strong band for the wild-type LS-BP with this protocol, no Coomassie-blue-stainable 
band corresponding to LS-BPAB14 was evident in the shock fluid from AE 4041 
pOX7AB14 (data not shown). Attempts to detect LIV-BP antisera cross-reacting 
material in the shock fluid by electrophoretic transfer of the electrophoresed proteins 
to nitrocellulose and incubation with appropriate antibodies were also unsuccessful. 
Since the LS-BPAB14 was expressed and secreted in spheroplasts (Fig. 3) and 
expressed and processed in whole cells (Fig. 4A), we concluded that substantial 
amounts of the LS-BPAB14 must have been secreted into the periplasm and then 
degraded rapidly enough to prevent the accumulation of LS-BPAB 14 to any significant 
steady-state level. 
Sequence of the 814 Deletion 
Since only LS-BPAB14 appeared to retain the correct reading frame, we chose 
to concentrate on this deletion for further studies. We determined the DNA sequence 
of the affected portion of the LS-BPAB 14 gene by conventional methods [2 11. Figure 
5 shows the results of the DNA sequencing experiment. LS-BPAB14 was fused so 
that it maintained the correct reading frame and contained a deletion of 78 amino 
acids from residue 234 (of the mature LS-BP) to residue 312. 
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Fig. 5. Exact location of the amino acids removed in the LS-BPAB14 deletion. The DNA sequence of 
the relevant portion of pOX7AB14 was determined by the method of Maxam and Gilbert [21] and 
compared to the known sequence of the LS-BP gene [Landick and Oxender, in preparation] to precisely 
map the deletion as shown. 
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Degradation of LS-BPAB14 by Periplasmic Proteases 
As a final test of the hypothesis that the LS-BPABl4 was degraded by peri- 
plasmic proteases, we examined the stability of partially purified LS-BPAB 14 when 
it was incubated with osmotic shock fluid proteins in vitro. Osmotic shock fluid was 
isolated from strain AE 84 (as AE 404 but recA+ livH+ thyA) by the method of Neu 
and Heppel [25]. LS-BPAB14 was labeled with [35S]methionine in spheroplasts of 
AE 404/pOX7AB14. After removal of the spheroplasts by centrifugation and filtration 
through Sephadex G-25, the [35S]methionine-labeled LS-BPAB 14 was divided into 
aliquots and incubated with increasing concentrations of osmotic shock fluid protein. 
As shown in Figure 6, at concentrations of osmotic shock fluid protein above 50 pg/ 
ml the LS-BPAB14 was degraded in 15 min at 37°C while the wild-type LS-BP was 
left intact. From these results we concluded that removal of the 78 amino acids 
missing in LS-BPAB 14 caused the deleted protein to become susceptible to degrada- 
tion by periplasmic proteases while the wild-type LS-BP is resistant to attack. We 
infer from this that LS-BPAB 14 must fold into a conformation that renders the deleted 
protein susceptible to attack; all of the amino acid sequences present in LS-BPAB14 
are present in the LS-BP and, therefore, the primary sequence of LS-BPAB14 alone 
must not be recognized by the periplasmic proteases. 
DISCUSSION 
In this report we have described the construction of C-terminal deletions in the 
E coli LS-BP gene and studied the secretion, processing, and periplasmic degradation 
of the deleted proteins coded for by these genes. We have extensively characterized 
one of these deletion proteins, LS-BPAB14, by determining that 78 amino acid 
residues, from amino acid 234 to residue 312, are missing in this deletion. We have 
reasoned that the other two deletion proteins, LS-BPAC 16 and LS-BPAG 13, contain 
missense amino acid sequences at their C-termini. We have examined the secretion 
and processing of the deletion proteins in whoIe cells and spheroplasts and we have 
specifically tested the susceptibility of LS-BPAB 14 to degradation by periplasmic 
proteases . 
Five important conclusions can be drawn from this study: 
(1) Significant portions of the C-terminal amino acid sequences in the LS-BP 
are not required for processing and secretion of the protein into the periplasm. 
(2) LS-BP molecules containing C-terminal deletions are degraded by peri- 
plasmic proteases . 
(3) Altered conformation, and not a specific sequence, determines the suscepti- 
bility of the deleted proteins to periplasmic protease degradation. 
(4) LS-BP deletions that contain missense amino acid sequences at their 
C-termini are more rapidly degraded than the LS-BPAB 14 deletion which contains an 
internal deletion. 
( 5 )  CCCP inhibition of secretory protein processing can be used to detect 
synthesis of otherwise unstable periplasmic proteins. 
Randall [30] has observed that processing of the maltose-binding protein is not 
initiated until 80% of the polypeptide chain has been synthesized [30]. These findings 
have been interpreted as showing that a certain minimum length of the N-terminal 
region of a secretory protein is required for protein processing and secretion. In this 
report, the results suggest that the critical N-terminal region of the LS-BP must be 
234 amino acids or less. 
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Fig. 6 .  Degradation of partially purified LS-BPAB14 by osmotic shock fluid protein. Secreted proteins 
from AE 404ipOX7AB14 were isolated from the labeling medium of spheroplasts prepared and labeled 
as described in Experimental Procedures. The isolated labeling medium, after removal of spheroplasts 
by centrifugation, was loaded on a Sephadex G-25 column equilibrated with 10 mM KPO,, pH 6 ,  and 
the labeled secretory proteins were recovered in the same buffer from the void volume fractions. 
Osmotic shock fluid was prepared from strain AE 84 by conventional methods [27]. Fractions of the 
labeled secretory proteins were incubated at 37°C for I5 min in the presence of the indicated concentra- 
tions of osmotic shock fluid protein. The fractions were then immunoprecipitated as previously described 
[ 131 and electrophoresed through an 11 % polyacrylamide SDS gel. After electrophoresis, the bands 
corresponding to the LS-BPAB14 and the mixture of LS-BP and LIV-BP (labeled L-BP) were located by 
autoradiography (shown in the insert), cut from the gel, and counted in liquid scintillation fluid. The 
percentage of remaining LS-BPAB14 relative to the total LIV-BP, LS-BP, and LS-BPAB14 was calcu- 
lated without correction for the number of methionine residues in each protein and is plotted against the 
concentration of osmotic shock fluid protein present during the 37°C incubation. 
The observed degradation of the LS-BP deletions has important implications for 
the study of protein secretion in E coli. The ease with which the altered LS-BP 
molecules are degraded by periplasmic proteases suggests that analysis of proteins 
that are present may be an inadequate assay for the secretion of a given protein. 
Proteins not ordinarily found in the periplasmic space may be sensitive to proteolytic 
degradation while periplasmic proteins, such as the LS-BP, are not degraded by a 
variety of proteases even though they contain sequences normally hydrolyzed by these 
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proteases [ 161. Apparently, secretory proteins fold into conformations that protect 
them from proteolytic degradation. Much experimental effort is currently being 
directed at determining the structural requirements for protein secretion. Frequently, 
these experiments involve construction of fused protein molecules with signal se- 
quences from secreted proteins and altered or nonsecretory protein sequences in the 
mature portion of a protein. Appearance of these proteins in the periplasmic space as 
assayed by osmotic shock treatment [25] or release after lysozyme-EDTA treatment 
has been used as criteria for successful protein secretion. These criteria were used 
initially to conclude that a P-lactamase missing a small portion of its C-terminus was 
not secreted [26] although later work involving lysozyme and EDTA treatment and 
trypsin accessibility showed that the protein in question was secreted 1271. We were 
able to show that the spheroplast assay shown in Figure 3 and described elsewhere 
[13] was a reliable test of protein secretion, but even here, one should be aware of 
possible proteolysis of the secreted proteins (see Fig. 3 and Results). 
Degradation of secretory proteins by periplasmic proteases is equally important 
for current efforts to design proteins that can be synthesized and secreted in E coli or 
other bacteria in sufficient quantity to simplify large-scale purification. While some 
of these efforts have already been successful, most notably for insulin 1281, most of 
these have been directed at small proteins that are normally secreted in other orga- 
nisms. As these schemes are expanded to include larger proteins and proteins that are 
not ordinarily secreted, the issue of proteolytic degradation may become more 
important. 
The LS-BP C-terminal deletions described in this report may be useful in 
characterizing periplasnic proteases and in constructing mutant strains in which their 
activities are reduced or eliminated. It is already known that more than one peri- 
plasmic protease is present in E coli [5]. It will be important to determine if only one 
of these activities is responsible for the observed degradation of the LS-BP deletions. 
It may be possible to use altered secretory proteins such as the LS-BP deletions to 
screen mutant strains for loss of the periplasmic proteases. 
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